Trial Profile
A open, flexible dosing, phase III study to investigate the effect of milnacipran in patients with fibromyalgia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Milnacipran (Primary)
- Indications Fibromyalgia
- Focus Adverse reactions; Therapeutic Use
- 05 Dec 2015 New trial record